Related Experiment Video
Updated: Dec 26, 2025

Immunofluorescence Analysis of Endogenous and Exogenous Centromere-kinetochore Proteins
Published on: March 3, 2016
Gossypol inhibits cullin neddylation by targeting SAG-CUL5 and RBX1-CUL1 complexes
Qing Yu1, Zhiguo Hu2, Yanwen Shen1
1Cancer Institute of the 2nd Affiliated Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Abstract:
Cullin-RING E3 ligase (CRL) is the largest family of E3 ubiquitin ligase, responsible for ubiquitylation of ∼20% of cellular proteins. CRL plays an important role in many biological processes, particularly in cancers due to abnormal activation. CRL activation requires neddylation, an enzymatic cascade transferring small ubiquitin-like protein NEDD8 to a conserved lysine residue on cullin proteins. Recent studies have validated that neddylation is an attractive anticancer target. In this study, we report the establishment of an Alpha-Screen-based high throughput screen (HTS) assay for in vitro CUL5 neddylation, and screened a library of 17,000 compounds including FDA approved drugs, natural products and synthetic drug-like small-molecule compounds. Gossypol, a natural compound derived from cotton seed, was identified as an inhibitor of cullin neddylation. Biochemical studies showed that gossypol blocked neddylation of both CUL5 and CUL1 through direct binding to SAG-CUL5 or RBX1-CUL1 complex, and CUL5-H572 plays a key role for gossypol binding. On cellular level, gossypol inhibited cullin neddylation in a variety of cancer cell lines and selectively caused accumulation of NOXA and MCL1, the substrates of CUL5 and CUL1, respectively, in multiple cancer cell lines. Combination of gossypol with specific MCL1 inhibitor synergistically suppress growth of human cancer cells. Our study revealed a previously unknown anti-cancer mechanism of gossypol with potential to develop a new class of neddylation inhibitors.
Insights
Gossypol inhibits cullin neddylation, a key process for cancer-driving E3 ligases. This natural compound targets CUL5 and CUL1, leading to cancer cell death and offering a new anticancer strategy.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Cullin-RING E3 ligases (CRLs) ubiquitylate ~20% of cellular proteins and are crucial in biological processes.
- Abnormal CRL activation is implicated in cancer, necessitating targeted interventions.
- CRL activation depends on neddylation, the attachment of NEDD8 to cullins, making it an attractive anticancer target.
Purpose of the Study:
- To establish a high-throughput screening assay for CUL5 neddylation.
- To identify small molecules that inhibit cullin neddylation.
- To investigate the anticancer mechanism of identified inhibitors.
Main Methods:
- Developed an Alpha-Screen-based high-throughput screen (HTS) for in vitro CUL5 neddylation.
- Screened a library of 17,000 compounds, including FDA-approved drugs and natural products.
- Conducted biochemical and cellular assays to validate inhibitor activity and mechanism.
Main Results:
- Identified gossypol, a natural compound, as a potent inhibitor of cullin neddylation.
- Gossypol directly binds to SAG-CUL5 and RBX1-CUL1 complexes, inhibiting neddylation of CUL5 and CUL1.
- Gossypol treatment caused selective accumulation of NOXA and MCL1 (CRL substrates) in cancer cells.
- Combination therapy of gossypol and an MCL1 inhibitor synergistically suppressed cancer cell growth.
Conclusions:
- Gossypol exhibits a novel anticancer mechanism by inhibiting cullin neddylation.
- Gossypol's ability to modulate CRL substrate levels presents a new therapeutic avenue.
- This study highlights the potential of developing new neddylation inhibitors for cancer treatment.
Related Concept Videos
Negative Regulator Molecules
Anaphase Promoting Complex
Regulation of Nuclear Protein Sorting
Inhibition of Cdk Activity
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
GPCR Desensitization

